The Vancomycin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vancomycin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vancomycin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vancomycin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Daptomycin
Linezolid
Quinupristin
Ampicillin
Chloramphenicol
Others
Market segment by Application can be divided into
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection
The key market players for global Vancomycin market are listed below:
Pfizer
Eli Lilly and Company
CJ CheilJedang
Xellia Pharmaceuticals ApS
VIANEX
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix.
MicuRx Pharmaceuticals
Nabriva Therapeutics
NovaBay Pharmaceuticals
NovoBiotic Pharmaceuticals
Oragenics
Sealife Pharma
Taiwan Zhengde Pharmaceutical
Zhejiang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
North China Pharmaceutical
Shenwei Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vancomycin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vancomycin, with price, sales, revenue and global market share of Vancomycin in 2018 and 2019.
Chapter 3, the Vancomycin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vancomycin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vancomycin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vancomycin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Vancomycin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vancomycin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vancomycin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Global Vancomycin Market Size & Forecast
1.4.1 Global Vancomycin Sales in Value (2016-2026))
1.4.2 Global Vancomycin Sales in Volume (2016-2026)
1.4.3 Global Vancomycin Price by Type (2016-2026) & (US$/G)
1.5 Global Vancomycin Production Capacity Analysis
1.5.1 Global Vancomycin Total Production Capacity (2016-2026)
1.5.2 Global Vancomycin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vancomycin Market Drivers
1.6.2 Vancomycin Market Restraints
1.6.3 Vancomycin Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vancomycin Product and Services
2.1.4 Pfizer Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Vancomycin Product and Services
2.2.4 Eli Lilly and Company Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 CJ CheilJedang
2.3.1 CJ CheilJedang Details
2.3.2 CJ CheilJedang Major Business
2.3.3 CJ CheilJedang Vancomycin Product and Services
2.3.4 CJ CheilJedang Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Xellia Pharmaceuticals ApS
2.4.1 Xellia Pharmaceuticals ApS Details
2.4.2 Xellia Pharmaceuticals ApS Major Business
2.4.3 Xellia Pharmaceuticals ApS Vancomycin Product and Services
2.4.4 Xellia Pharmaceuticals ApS Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 VIANEX
2.5.1 VIANEX Details
2.5.2 VIANEX Major Business
2.5.3 VIANEX Vancomycin Product and Services
2.5.4 VIANEX Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Alchemia Limited
2.6.1 Alchemia Limited Details
2.6.2 Alchemia Limited Major Business
2.6.3 Alchemia Limited Vancomycin Product and Services
2.6.4 Alchemia Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Alvogen
2.7.1 Alvogen Details
2.7.2 Alvogen Major Business
2.7.3 Alvogen Vancomycin Product and Services
2.7.4 Alvogen Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Aphios Corporation
2.8.1 Aphios Corporation Details
2.8.2 Aphios Corporation Major Business
2.8.3 Aphios Corporation Vancomycin Product and Services
2.8.4 Aphios Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Cellceutix Corporation
2.9.1 Cellceutix Corporation Details
2.9.2 Cellceutix Corporation Major Business
2.9.3 Cellceutix Corporation Vancomycin Product and Services
2.9.4 Cellceutix Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Enanta Pharmaceuticals
2.10.1 Enanta Pharmaceuticals Details
2.10.2 Enanta Pharmaceuticals Major Business
2.10.3 Enanta Pharmaceuticals Vancomycin Product and Services
2.10.4 Enanta Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Helix BioMedix
2.11.1 Helix BioMedix Details
2.11.2 Helix BioMedix Major Business
2.11.3 Helix BioMedix Vancomycin Product and Services
2.11.4 Helix BioMedix Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 LegoChem Biosciences
2.12.1 LegoChem Biosciences Details
2.12.2 LegoChem Biosciences Major Business
2.12.3 LegoChem Biosciences Vancomycin Product and Services
2.12.4 LegoChem Biosciences Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Lytix Biopharma
2.13.1 Lytix Biopharma Details
2.13.2 Lytix Biopharma Major Business
2.13.3 Lytix Biopharma Vancomycin Product and Services
2.13.4 Lytix Biopharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 MGB Biopharma Limited
2.14.1 MGB Biopharma Limited Details
2.14.2 MGB Biopharma Limited Major Business
2.14.3 MGB Biopharma Limited Vancomycin Product and Services
2.14.4 MGB Biopharma Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Microbiotix.
2.15.1 Microbiotix. Details
2.15.2 Microbiotix. Major Business
2.15.3 Microbiotix. Vancomycin Product and Services
2.15.4 Microbiotix. Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 MicuRx Pharmaceuticals
2.16.1 MicuRx Pharmaceuticals Details
2.16.2 MicuRx Pharmaceuticals Major Business
2.16.3 MicuRx Pharmaceuticals Vancomycin Product and Services
2.16.4 MicuRx Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Nabriva Therapeutics
2.17.1 Nabriva Therapeutics Details
2.17.2 Nabriva Therapeutics Major Business
2.17.3 Nabriva Therapeutics Vancomycin Product and Services
2.17.4 Nabriva Therapeutics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 NovaBay Pharmaceuticals
2.18.1 NovaBay Pharmaceuticals Details
2.18.2 NovaBay Pharmaceuticals Major Business
2.18.3 NovaBay Pharmaceuticals Vancomycin Product and Services
2.18.4 NovaBay Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 NovoBiotic Pharmaceuticals
2.19.1 NovoBiotic Pharmaceuticals Details
2.19.2 NovoBiotic Pharmaceuticals Major Business
2.19.3 NovoBiotic Pharmaceuticals Vancomycin Product and Services
2.19.4 NovoBiotic Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Oragenics
2.20.1 Oragenics Details
2.20.2 Oragenics Major Business
2.20.3 Oragenics Vancomycin Product and Services
2.20.4 Oragenics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Sealife Pharma
2.21.1 Sealife Pharma Details
2.21.2 Sealife Pharma Major Business
2.21.3 Sealife Pharma Vancomycin Product and Services
2.21.4 Sealife Pharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Taiwan Zhengde Pharmaceutical
2.22.1 Taiwan Zhengde Pharmaceutical Details
2.22.2 Taiwan Zhengde Pharmaceutical Major Business
2.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Product and Services
2.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Zhejiang Pharmaceutical
2.23.1 Zhejiang Pharmaceutical Details
2.23.2 Zhejiang Pharmaceutical Major Business
2.23.3 Zhejiang Pharmaceutical Vancomycin Product and Services
2.23.4 Zhejiang Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Zhejiang Haizheng Pharmaceutical
2.24.1 Zhejiang Haizheng Pharmaceutical Details
2.24.2 Zhejiang Haizheng Pharmaceutical Major Business
2.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Product and Services
2.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 North China Pharmaceutical
2.25.1 North China Pharmaceutical Details
2.25.2 North China Pharmaceutical Major Business
2.25.3 North China Pharmaceutical Vancomycin Product and Services
2.25.4 North China Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Shenwei Pharmaceutical
2.26.1 Shenwei Pharmaceutical Details
2.26.2 Shenwei Pharmaceutical Major Business
2.26.3 Shenwei Pharmaceutical Vancomycin Product and Services
2.26.4 Shenwei Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vancomycin Sales by Manufacturer
3.1 Global Vancomycin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vancomycin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vancomycin
3.4 Market Concentration Rate
3.4.1 Top 3 Vancomycin Manufacturer Market Share
3.4.2 Top 6 Vancomycin Manufacturer Market Share
3.5 Global Vancomycin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vancomycin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vancomycin Market Size by Region
4.1.1 Global Vancomycin Sales in Volume by Region (2016-2026)
4.1.2 Global Vancomycin Revenue by Region (2016-2026)
4.2 North America Vancomycin Revenue (2016-2026)
4.3 Europe Vancomycin Revenue (2016-2026)
4.4 Asia-Pacific Vancomycin Revenue (2016-2026)
4.5 South America Vancomycin Revenue (2016-2026)
4.6 Middle East and Africa Vancomycin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vancomycin Sales in Volume by Type (2016-2026)
5.2 Global Vancomycin Revenue by Type (2016-2026)
5.3 Global Vancomycin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vancomycin Sales in Volume by Application (2016-2026)
6.2 Global Vancomycin Revenue by Application (2016-2026)
6.3 Global Vancomycin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vancomycin Sales by Type (2016-2026)
7.2 North America Vancomycin Sales by Application (2016-2026)
7.3 North America Vancomycin Market Size by Country
7.3.1 North America Vancomycin Sales in Volume by Country (2016-2026)
7.3.2 North America Vancomycin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vancomycin Sales by Type (2016-2026)
8.2 Europe Vancomycin Sales by Application (2016-2026)
8.3 Europe Vancomycin Market Size by Country
8.3.1 Europe Vancomycin Sales in Volume by Country (2016-2026)
8.3.2 Europe Vancomycin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vancomycin Sales by Type (2016-2026)
9.2 Asia-Pacific Vancomycin Sales by Application (2016-2026)
9.3 Asia-Pacific Vancomycin Market Size by Region
9.3.1 Asia-Pacific Vancomycin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vancomycin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vancomycin Sales by Type (2016-2026)
10.2 South America Vancomycin Sales by Application (2016-2026)
10.3 South America Vancomycin Market Size by Country
10.3.1 South America Vancomycin Sales in Volume by Country (2016-2026)
10.3.2 South America Vancomycin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vancomycin Sales by Type (2016-2026)
11.2 Middle East & Africa Vancomycin Sales by Application (2016-2026)
11.3 Middle East & Africa Vancomycin Market Size by Country
11.3.1 Middle East & Africa Vancomycin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vancomycin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vancomycin Typical Distributors
12.3 Vancomycin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Vancomycin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vancomycin Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Vancomycin Product and Services
Table 6. Pfizer Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Major Business
Table 9. Eli Lilly and Company Vancomycin Product and Services
Table 10. Eli Lilly and Company Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CJ CheilJedang Basic Information, Manufacturing Base and Competitors
Table 12. CJ CheilJedang Major Business
Table 13. CJ CheilJedang Vancomycin Product and Services
Table 14. CJ CheilJedang Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Xellia Pharmaceuticals ApS Basic Information, Manufacturing Base and Competitors
Table 16. Xellia Pharmaceuticals ApS Major Business
Table 17. Xellia Pharmaceuticals ApS Vancomycin Product and Services
Table 18. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. VIANEX Basic Information, Manufacturing Base and Competitors
Table 20. VIANEX Major Business
Table 21. VIANEX Vancomycin Product and Services
Table 22. VIANEX Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Alchemia Limited Basic Information, Manufacturing Base and Competitors
Table 24. Alchemia Limited Major Business
Table 25. Alchemia Limited Vancomycin Product and Services
Table 26. Alchemia Limited Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Alvogen Basic Information, Manufacturing Base and Competitors
Table 28. Alvogen Major Business
Table 29. Alvogen Vancomycin Product and Services
Table 30. Alvogen Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Aphios Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Aphios Corporation Major Business
Table 33. Aphios Corporation Vancomycin Product and Services
Table 34. Aphios Corporation Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Cellceutix Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Cellceutix Corporation Major Business
Table 37. Cellceutix Corporation Vancomycin Product and Services
Table 38. Cellceutix Corporation Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Enanta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Enanta Pharmaceuticals Major Business
Table 41. Enanta Pharmaceuticals Vancomycin Product and Services
Table 42. Enanta Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Helix BioMedix Basic Information, Manufacturing Base and Competitors
Table 44. Helix BioMedix Major Business
Table 45. Helix BioMedix Vancomycin Product and Services
Table 46. Helix BioMedix Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. LegoChem Biosciences Basic Information, Manufacturing Base and Competitors
Table 48. LegoChem Biosciences Major Business
Table 49. LegoChem Biosciences Vancomycin Product and Services
Table 50. LegoChem Biosciences Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
Table 52. Lytix Biopharma Major Business
Table 53. Lytix Biopharma Vancomycin Product and Services
Table 54. Lytix Biopharma Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. MGB Biopharma Limited Basic Information, Manufacturing Base and Competitors
Table 56. MGB Biopharma Limited Major Business
Table 57. MGB Biopharma Limited Vancomycin Product and Services
Table 58. MGB Biopharma Limited Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Microbiotix. Basic Information, Manufacturing Base and Competitors
Table 60. Microbiotix. Major Business
Table 61. Microbiotix. Vancomycin Product and Services
Table 62. Microbiotix. Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. MicuRx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. MicuRx Pharmaceuticals Major Business
Table 65. MicuRx Pharmaceuticals Vancomycin Product and Services
Table 66. MicuRx Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Nabriva Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Nabriva Therapeutics Major Business
Table 69. Nabriva Therapeutics Vancomycin Product and Services
Table 70. Nabriva Therapeutics Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. NovaBay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. NovaBay Pharmaceuticals Major Business
Table 73. NovaBay Pharmaceuticals Vancomycin Product and Services
Table 74. NovaBay Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. NovoBiotic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. NovoBiotic Pharmaceuticals Major Business
Table 77. NovoBiotic Pharmaceuticals Vancomycin Product and Services
Table 78. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Oragenics Basic Information, Manufacturing Base and Competitors
Table 80. Oragenics Major Business
Table 81. Oragenics Vancomycin Product and Services
Table 82. Oragenics Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sealife Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Sealife Pharma Major Business
Table 85. Sealife Pharma Vancomycin Product and Services
Table 86. Sealife Pharma Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Taiwan Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Taiwan Zhengde Pharmaceutical Major Business
Table 89. Taiwan Zhengde Pharmaceutical Vancomycin Product and Services
Table 90. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Zhejiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Zhejiang Pharmaceutical Major Business
Table 93. Zhejiang Pharmaceutical Vancomycin Product and Services
Table 94. Zhejiang Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Zhejiang Haizheng Pharmaceutical Major Business
Table 97. Zhejiang Haizheng Pharmaceutical Vancomycin Product and Services
Table 98. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. North China Pharmaceutical Major Business
Table 101. North China Pharmaceutical Vancomycin Product and Services
Table 102. North China Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Shenwei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Shenwei Pharmaceutical Major Business
Table 105. Shenwei Pharmaceutical Vancomycin Product and Services
Table 106. Shenwei Pharmaceutical Vancomycin Sales (KG), Price (US$/G), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Global Vancomycin Sales by Manufacturer (2019-2021e) & (KG)
Table 108. Global Vancomycin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 109. Market Position of Manufacturers in Vancomycin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 110. Global Vancomycin Production Capacity by Company, (KG): 2020 VS 2021
Table 111. Head Office and Vancomycin Production Site of Key Manufacturer
Table 112. Vancomycin New Entrant and Capacity Expansion Plans
Table 113. Vancomycin Mergers & Acquisitions in the Past Five Years
Table 114. Global Vancomycin Sales by Region (2016-2021e) & (KG)
Table 115. Global Vancomycin Sales by Region (2021-2026) & (KG)
Table 116. Global Vancomycin Revenue by Region (2016-2021e) & (USD Million)
Table 117. Global Vancomycin Revenue by Region (2021-2026) & (USD Million)
Table 118. Global Vancomycin Sales by Type (2016-2021e) & (KG)
Table 119. Global Vancomycin Sales by Type (2021-2026) & (KG)
Table 120. Global Vancomycin Revenue by Type (2016-2021e) & (USD Million)
Table 121. Global Vancomycin Revenue by Type (2021-2026) & (USD Million)
Table 122. Global Vancomycin Price by Type (2016-2021e) & (US$/G)
Table 123. Global Vancomycin Price by Type (2021-2026) & (US$/G)
Table 124. Global Vancomycin Sales by Application (2016-2021e) & (KG)
Table 125. Global Vancomycin Sales by Application (2021-2026) & (KG)
Table 126. Global Vancomycin Revenue by Application (2016-2021e) & (USD Million)
Table 127. Global Vancomycin Revenue by Application (2021-2026) & (USD Million)
Table 128. Global Vancomycin Price by Application (2016-2021e) & (US$/G)
Table 129. Global Vancomycin Price by Application (2021-2026) & (US$/G)
Table 130. North America Vancomycin Sales by Country (2016-2021e) & (KG)
Table 131. North America Vancomycin Sales by Country (2021-2026) & (KG)
Table 132. North America Vancomycin Revenue by Country (2016-2021e) & (USD Million)
Table 133. North America Vancomycin Revenue by Country (2021-2026) & (USD Million)
Table 134. North America Vancomycin Sales by Type (2016-2021e) & (KG)
Table 135. North America Vancomycin Sales by Type (2021-2026) & (KG)
Table 136. North America Vancomycin Sales by Application (2016-2021e) & (KG)
Table 137. North America Vancomycin Sales by Application (2021-2026) & (KG)
Table 138. Europe Vancomycin Sales by Country (2016-2021e) & (KG)
Table 139. Europe Vancomycin Sales by Country (2021-2026) & (KG)
Table 140. Europe Vancomycin Revenue by Country (2016-2021e) & (USD Million)
Table 141. Europe Vancomycin Revenue by Country (2021-2026) & (USD Million)
Table 142. Europe Vancomycin Sales by Type (2016-2021e) & (KG)
Table 143. Europe Vancomycin Sales by Type (2021-2026) & (KG)
Table 144. Europe Vancomycin Sales by Application (2016-2021e) & (KG)
Table 145. Europe Vancomycin Sales by Application (2021-2026) & (KG)
Table 146. Asia-Pacific Vancomycin Sales by Region (2016-2021e) & (KG)
Table 147. Asia-Pacific Vancomycin Sales by Region (2021-2026) & (KG)
Table 148. Asia-Pacific Vancomycin Revenue by Region (2016-2021e) & (USD Million)
Table 149. Asia-Pacific Vancomycin Revenue by Region (2021-2026) & (USD Million)
Table 150. Asia-Pacific Vancomycin Sales by Type (2016-2021e) & (KG)
Table 151. Asia-Pacific Vancomycin Sales by Type (2021-2026) & (KG)
Table 152. Asia-Pacific Vancomycin Sales by Application (2016-2021e) & (KG)
Table 153. Asia-Pacific Vancomycin Sales by Application (2021-2026) & (KG)
Table 154. South America Vancomycin Sales by Country (2016-2021e) & (KG)
Table 155. South America Vancomycin Sales by Country (2021-2026) & (KG)
Table 156. South America Vancomycin Revenue by Country (2016-2021e) & (USD Million)
Table 157. South America Vancomycin Revenue by Country (2021-2026) & (USD Million)
Table 158. South America Vancomycin Sales by Type (2016-2021e) & (KG)
Table 159. South America Vancomycin Sales by Type (2021-2026) & (KG)
Table 160. South America Vancomycin Sales by Application (2016-2021e) & (KG)
Table 161. South America Vancomycin Sales by Application (2021-2026) & (KG)
Table 162. Middle East & Africa Vancomycin Sales by Country (2016-2021e) & (KG)
Table 163. Middle East & Africa Vancomycin Sales by Country (2021-2026) & (KG)
Table 164. Middle East & Africa Vancomycin Revenue by Country (2016-2021e) & (USD Million)
Table 165. Middle East & Africa Vancomycin Revenue by Country (2021-2026) & (USD Million)
Table 166. Middle East & Africa Vancomycin Sales by Type (2016-2021e) & (KG)
Table 167. Middle East & Africa Vancomycin Sales by Type (2021-2026) & (KG)
Table 168. Middle East & Africa Vancomycin Sales by Application (2016-2021e) & (KG)
Table 169. Middle East & Africa Vancomycin Sales by Application (2021-2026) & (KG)
Table 170. Direct Channel Pros & Cons
Table 171. Indirect Channel Pros & Cons
Table 172. Vancomycin Typical Distributors
Table 173. Vancomycin Typical Customers
List of Figures
Figure 1. Vancomycin Picture
Figure 2. Global Vancomycin Sales Market Share by Type in 2020
Figure 3. Daptomycin
Figure 4. Linezolid
Figure 5. Quinupristin
Figure 6. Ampicillin
Figure 7. Chloramphenicol
Figure 8. Others
Figure 9. Global Vancomycin Sales Market Share by Application in 2020
Figure 10. Sepsis
Figure 11. Lung Infection
Figure 12. Skin Soft Tissue Infection
Figure 13. Colitis & Intestinal Inflammation
Figure 14. To Prevent Infection
Figure 15. Global Vancomycin Market Size, (USD Million) & (KG): 2020 VS 2021 VS 2026
Figure 16. Global Vancomycin Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Vancomycin Sales (2016-2026) & (KG)
Figure 18. Global Vancomycin Price by Type (2016-2026) & (US$/G)
Figure 19. Global Vancomycin Production Capacity (2016-2026) & (KG)
Figure 20. Global Vancomycin Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Vancomycin Market Drivers
Figure 22. Vancomycin Market Restraints
Figure 23. Vancomycin Market Trends
Figure 24. Global Vancomycin Sales Market Share by Manufacturer in 2020
Figure 25. Global Vancomycin Revenue Market Share by Manufacturer in 2020
Figure 26. Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Vancomycin Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Vancomycin Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Vancomycin Sales Market Share by Region (2016-2026)
Figure 30. Global Vancomycin Revenue Market Share by Region (2016-2026)
Figure 31. North America Vancomycin Revenue (2016-2026) & (USD Million)
Figure 32. Europe Vancomycin Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Vancomycin Revenue (2016-2026) & (USD Million)
Figure 34. South America Vancomycin Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Vancomycin Revenue (2016-2026) & (USD Million)
Figure 36. Global Vancomycin Sales Market Share by Type (2016-2026)
Figure 37. Global Vancomycin Revenue Market Share by Type (2016-2026)
Figure 38. Global Vancomycin Price by Type (2016-2026) & (US$/G)
Figure 39. Global Vancomycin Sales Market Share by Application (2016-2026)
Figure 40. Global Vancomycin Revenue Market Share by Application (2016-2026)
Figure 41. Global Vancomycin Price by Application (2016-2026) & (US$/G)
Figure 42. North America Vancomycin Sales Market Share by Type (2016-2026)
Figure 43. North America Vancomycin Sales Market Share by Application (2016-2026)
Figure 44. North America Vancomycin Sales Market Share by Country (2016-2026)
Figure 45. North America Vancomycin Revenue Market Share by Country (2016-2026)
Figure 46. United States Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Vancomycin Sales Market Share by Type (2016-2026)
Figure 50. Europe Vancomycin Sales Market Share by Application (2016-2026)
Figure 51. Europe Vancomycin Sales Market Share by Country (2016-2026)
Figure 52. Europe Vancomycin Revenue Market Share by Country (2016-2026)
Figure 53. Germany Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Vancomycin Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Vancomycin Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Vancomycin Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Vancomycin Revenue Market Share by Region (2016-2026)
Figure 62. China Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Vancomycin Sales Market Share by Type (2016-2026)
Figure 69. South America Vancomycin Sales Market Share by Application (2016-2026)
Figure 70. South America Vancomycin Sales Market Share by Country (2016-2026)
Figure 71. South America Vancomycin Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Vancomycin Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Vancomycin Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Vancomycin Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Vancomycin Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Vancomycin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source